R&D Desk

21
Oct
The first real verdicts are in for AI-discovered drugs

The first real verdicts are in for AI-discovered drugs

No AI-designed molecule has full FDA approval yet. But the first AI-native candidate has reached phase 3, the mid-stage data has started arriving, and the question has changed from 'how fast?' to 'do they work?'
2 min read